BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10893668)

  • 1. An uncommon G375C substitution in a newborn with achondroplasia.
    Addor MC; Gudinchet F; Truttmann A; Schorderet DF
    Genet Couns; 2000; 11(2):169-74. PubMed ID: 10893668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondroplasia.
    Superti-Furga A; Eich G; Bucher HU; Wisser J; Giedion A; Gitzelmann R; Steinmann B
    Eur J Pediatr; 1995 Mar; 154(3):215-9. PubMed ID: 7758520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and molecular characteristics of Thai patients with achondroplasia.
    Shotelersuk V; Ittiwut C; Srivuthana S; Wacharasindhu S; Aroonparkmongkol S; Mutirangura A; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2001 Jun; 32(2):429-33. PubMed ID: 11556601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel missense mutation Ile538Val in the fibroblast growth factor receptor 3 in hypochondroplasia. Mutations in brief no. 122. Online.
    Grigelioniené G; Hagenäs L; Eklöf O; Neumeyer L; Haereid PE; Anvret M
    Hum Mutat; 1998; 11(4):333. PubMed ID: 10215410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An improved methodology for the detection of the common mutation in the FGFR3 gene responsible for achondroplasia.
    Lanning RW; Brown CA
    Hum Mutat; 1997; 10(6):496-9. PubMed ID: 9401015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achondroplasia in diverse Jewish and Arab populations in Israel: clinical and molecular characterization.
    Falik-Zaccai TC; Shachak E; Abeliovitch D; Lerer I; Shefer R; Carmi R; Ries L; Friedman M; Shohat M; Borochowitz Z
    Isr Med Assoc J; 2000 Aug; 2(8):601-4. PubMed ID: 10979354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia.
    Bellus GA; McIntosh I; Smith EA; Aylsworth AS; Kaitila I; Horton WA; Greenhaw GA; Hecht JT; Francomano CA
    Nat Genet; 1995 Jul; 10(3):357-9. PubMed ID: 7670477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achondroplasia in Turkey is defined by recurrent G380R mutation of the FGFR3 gene.
    Pehlivan S; Ozkinay F; Okutman O; Coğulu O; Ozcan A; Cankaya T; Ulgenalp A
    Turk J Pediatr; 2003; 45(2):99-101. PubMed ID: 12921294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achondroplasia is defined by recurrent G380R mutations of FGFR3.
    Bellus GA; Hefferon TW; Ortiz de Luna RI; Hecht JT; Horton WA; Machado M; Kaitila I; McIntosh I; Francomano CA
    Am J Hum Genet; 1995 Feb; 56(2):368-73. PubMed ID: 7847369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential activation of cysteine-substitution mutants of fibroblast growth factor receptor 3 is determined by cysteine localization.
    Adar R; Monsonego-Ornan E; David P; Yayon A
    J Bone Miner Res; 2002 May; 17(5):860-8. PubMed ID: 12009017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Differentiation of achondroplasia and other similar genetic dwarfism by FGFR3 gene analysis].
    Zhang Y; Yu W; Shen M; Fang Q; Fan M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Aug; 17(4):252-5. PubMed ID: 10932008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acanthosis nigricans in a boy with achondroplasia due to the classical Gly380Arg mutation in FGFR3.
    Van Esch H; Fryns JE
    Genet Couns; 2004; 15(3):375-7. PubMed ID: 15517832
    [No Abstract]   [Full Text] [Related]  

  • 13. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia.
    Naski MC; Wang Q; Xu J; Ornitz DM
    Nat Genet; 1996 Jun; 13(2):233-7. PubMed ID: 8640234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations of the fibroblast growth factor receptor-3 gene in one familial and six sporadic cases of achondroplasia in Japanese patients.
    Ikegawa S; Fukushima Y; Isomura M; Takada F; Nakamura Y
    Hum Genet; 1995 Sep; 96(3):309-11. PubMed ID: 7649548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia.
    Rousseau F; Bonaventure J; Legeai-Mallet L; Pelet A; Rozet JM; Maroteaux P; Le Merrer M; Munnich A
    Nature; 1994 Sep; 371(6494):252-4. PubMed ID: 8078586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achondroplasia with the FGFR3 1138g-->a (G380R) mutation in two sibs sharing a 4p haplotype derived from their unaffected father.
    Sobetzko D; Braga S; Rüdeberg A; Superti-Furga A
    J Med Genet; 2000 Dec; 37(12):958-9. PubMed ID: 11186940
    [No Abstract]   [Full Text] [Related]  

  • 17. Atypical radiological findings in achondroplasia with uncommon mutation of the fibroblast growth factor receptor-3 (FGFR-3) gene (Gly to Cys transition at codon 375).
    Nishimura G; Fukushima Y; Ohashi H; Ikegawa S
    Am J Med Genet; 1995 Nov; 59(3):393-5. PubMed ID: 8599370
    [No Abstract]   [Full Text] [Related]  

  • 18. [Detection of fibroblast growth factor receptor 3 gene mutation at nucleotide 1138 site in congenita achondroplasia patients].
    Ni J; Lu G; Wang W; Chen F; Qin H; Wang D
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):205-8. PubMed ID: 12048679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGFR3 gene mutation (Gly380Arg) with achondroplasia and i(21q) Down syndrome: phenotype-genotype correlation.
    Chen H; Mu X; Sonoda T; Kim KC; Dailey K; Martinez J; Tuck-Muller C; Wertelecki W
    South Med J; 2000 Jun; 93(6):622-4. PubMed ID: 10881785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predominance of the mutation at 1138 of the cDNA for the fibroblast growth factor receptor 3 in Japanese patients with achondroplasia.
    Tonoki H; Nakae J; Tajima T; Shinohara N; Monji J; Satoh S; Fujieda K
    Jpn J Hum Genet; 1995 Dec; 40(4):347-9. PubMed ID: 8851771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.